Premier Research Names Susan Stansfield, PhD Executive VP, Clinical Development
PHILADELPHIA, Jan. 11, 2012 /PRNewswire/ -- Premier Research Group announces the appointment of Susan C. Stansfield, PhD to the position of Executive Vice President, Clinical Development. In this position, Dr. Stansfield will have global responsibility for leading and developing the company's clinical trial management services provided to the biopharmaceutical industry.
"Sue's deep industry knowledge and proven leadership skills will be pivotal in enhancing the value our clinical development organization provides to our customers," commented Dr. Ludo Reynders, Chief Executive Officer. "As demand for our services continues to grow, Sue will focus on ensuring that scientific and operational excellence remains at the heart of our organization. Sue's exceptional skills and experience in the areas of program and project management will be invaluable in providing superior and appropriate services to our customers in today's rapidly changing drug development world."
Dr. Stansfield comes to Premier Research with an exceptional track record of more than 25 years in the pharmaceutical and contract research industries. Dr. Stansfield worked at three of the leading clinical service organizations (PRA, PPD and Quintiles) taking increasingly responsible leadership roles in project management and clinical operations. This included responsibility for 2,000 staff located in 50 countries. Dr. Stansfield holds a Doctorate in Neuropharmacology from Reading University in the UK and a Bachelor in Science from Nottingham University.
About Premier Research
Premier Research is a professional services company providing clinical development services to the pharmaceutical, biotechnology, and medical device industries. Founded in 1989 and headquartered in Philadelphia, USA, the company has 21 offices across North America and Europe and operates in over 30 countries worldwide. The company is a leader in performing clinical research in the analgesia, oncology, pediatrics, medical device and neurosciences areas. Additionally, it provides a strong strategic sourcing group that supports customers in their resource planning and management.
The company offers a comprehensive series of services for every phase of clinical development including, regulatory affairs, clinical trial management, medical affairs and strategic consulting, pharmacovigilance, data operations, biostatistics, medical writing, interactive response technologies, and quality assurance.
SOURCE Premier Research Group